Literature DB >> 15273147

Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones.

Masayasu Ito1, Mitsuru Yasuda, Shigeaki Yokoi, Shin-ichi Ito, Yoshito Takahashi, Satoshi Ishihara, Shin-ichi Maeda, Takashi Deguchi.   

Abstract

Four hundred sixty-two clinical isolates of Neisseria gonorrhoeae recovered from 1999 through 2002 in central Japan were examined for MICs of antimicrobial agents. The majority was sensitive to ceftriaxone and spectinomycin, but a remarkable increase in isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones was observed from 2001 through 2002.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15273147      PMCID： PMC478532          DOI： 10.1128/AAC.48.8.3185-3187.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan.

Authors:  T Muratani; S Akasaka; T Kobayashi; Y Yamada; H Inatomi; K Takahashi; T Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998.

Authors:  M Tanaka; H Nakayama; M Haraoka; T Saika
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.

Authors:  S Akasaka; T Muratani; Y Yamada; H Inatomi; K Takahashi; T Matsumoto
Journal:  J Infect Chemother       Date:  2001-03       Impact factor: 2.211

Review 4.  Prevention of drug access to bacterial targets: permeability barriers and active efflux.

Authors:  H Nikaido
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

5.  Contribution of a TEM-1-like beta-lactamase to penicillin resistance in Neisseria gonorrhoeae.

Authors:  S Bergström; L Norlander; A Norqvist; S Normark
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

6.  The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds.

Authors:  Corinne Rouquette-Loughlin; Steven A Dunham; Michael Kuhn; Jacqueline T Balthazar; William M Shafer
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

7.  Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles.

Authors:  T Deguchi; M Yasuda; M Nakano; S Ozeki; T Ezaki; I Saito; Y Kawada
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

8.  Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system.

Authors:  K E Hagman; W Pan; B G Spratt; J T Balthazar; R C Judd; W M Shafer
Journal:  Microbiology       Date:  1995-03       Impact factor: 2.777

9.  Penicillin-binding protein 2 genes of non-beta-lactamase-producing, penicillin-resistant strains of Neisseria gonorrhoeae.

Authors:  C G Dowson; A E Jephcott; K R Gough; B G Spratt
Journal:  Mol Microbiol       Date:  1989-01       Impact factor: 3.501

10.  Gonococcal resistance to beta-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus.

Authors:  M J Gill; S Simjee; K Al-Hattawi; B D Robertson; C S Easmon; C A Ison
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191
View more
  27 in total

1.  Management of pharyngeal gonorrhea is crucial to prevent the emergence and spread of antibiotic-resistant Neisseria gonorrhoeae.

Authors:  Takashi Deguchi; Mitsuru Yasuda; Shin Ito
Journal:  Antimicrob Agents Chemother       Date:  2012-07       Impact factor: 5.191

2.  A doctor's dilemma: choices amidst change.

Authors:  P Frederick Sparling
Journal:  J Clin Invest       Date:  2015-08-04       Impact factor: 14.808

3.  Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae.

Authors:  Sho Takahata; Nami Senju; Yumi Osaki; Takuji Yoshida; Takashi Ida
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

4.  Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan.

Authors:  Masayasu Ito; Takashi Deguchi; Koh-Suke Mizutani; Mitsuru Yasuda; Shigeaki Yokoi; Shin-Ichi Ito; Yoshito Takahashi; Satoshi Ishihara; Yoshiaki Kawamura; Takayuki Ezaki
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Alanine 501 Mutations in Penicillin-Binding Protein 2 from Neisseria gonorrhoeae: Structure, Mechanism, and Effects on Cephalosporin Resistance and Biological Fitness.

Authors:  Joshua Tomberg; Alena Fedarovich; Leah R Vincent; Ann E Jerse; Magnus Unemo; Christopher Davies; Robert A Nicholas
Journal:  Biochemistry       Date:  2017-02-16       Impact factor: 3.162

6.  Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.

Authors:  Vanessa G Allen; David J Farrell; Anuradha Rebbapragada; Jingyuan Tan; Nathalie Tijet; Stephen J Perusini; Lynn Towns; Stephen Lo; Donald E Low; Roberto G Melano
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

Review 7.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

8.  MpeR regulates the mtr efflux locus in Neisseria gonorrhoeae and modulates antimicrobial resistance by an iron-responsive mechanism.

Authors:  Alexandra Dubon Mercante; Lydgia Jackson; Paul J T Johnson; Virginia A Stringer; David W Dyer; William M Shafer
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.191

Review 9.  Expedited partner therapy for sexually transmitted infections.

Authors:  Matthew Hogben; Sarah Kidd; Gale R Burstein
Journal:  Curr Opin Obstet Gynecol       Date:  2012-10       Impact factor: 1.927

Review 10.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.